OnCo

FOXO3 (Forkhead box protein O3) is a gene that drives cell growth when it is altered. The public catalogues list it as an oncogene driver and a fusion partner, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Breast cancer, Skin cancer, Acute myeloid leukaemia and 1 more. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.

Biology

Transcriptional activator that recognises and binds to the DNA sequence 5'-[AG]TAAA[TC]A-3' and regulates different processes, such as apoptosis and autophagy. Acts as a positive regulator of autophagy in skeletal muscle: in starved cells, enters the nucleus following dephosphorylation and binds the promoters of autophagy genes, such as GABARAP1L, MAP1LC3B and ATG12, thereby activating their expression, resulting in proteolysis of skeletal muscle proteins. Triggers apoptosis in the absence of survival factors, including neuronal cell death upon oxidative stress. Participates in post-transcriptional regulation of MYC: following phosphorylation by MAPKAPK5, promotes induction of miR-34b and miR-34c expression, 2 post-transcriptional regulators of MYC that bind to the 3'UTR of MYC transcript and prevent its translation. In response to metabolic stress, translocates into the mitochondria where it promotes mtDNA transcription. In response to metabolic stress, translocates into the mitochondria where it promotes mtDNA transcription. Location: Cytoplasm, cytosol; Nucleus; Mitochondrion matrix; Mitochondrion outer membrane (UniProt). Locus 6q21 (HGNC).

Where it is found
  • Breast cancer: Open Targets association 0.54 with breast cancer (MONDO_0007254)
  • Skin cancer: Open Targets association 0.52 with skin cancer (MONDO_0002898)
  • Acute myeloid leukaemia: IntOGen driver in 1 cohort (AML)
  • Medulloblastoma: IntOGen driver in 1 cohort (MBL)
Class: oncogene · Gene: FOXO3 · Facts checked 2026-09-23 · Target page

External identifiers

Built from HGNC, Ensembl, UniProt and ChEMBL ids

Products by modality and phase

Browse products →

No product in the corpus is aimed at this target yet.

No trial in the corpus names this target or one of its products.

Resistance routes

Unaddressed routes →

The resistance atlas has no route that names this target.

No pathway diagram carries this target as a node.

Companion diagnostics

Assay registry →

No companion diagnostic in the registry measures this target.

Preclinical models

All models →

No model entry for this target yet; check the cancer entries on the models page.

No open questions recorded for this target yet. Suggest one.

Literature

Preprints →
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this target: (TITLE:"FOXO3" OR ABSTRACT:"FOXO3" OR TITLE:"forkhead box O3" OR ABSTRACT:"forkhead box O3" OR TITLE:"Forkhead box protein O3" OR ABSTRACT:"Forkhead box protein O3" OR TITLE:"AF6q21" OR ABSTRACT:"AF6q21" OR TITLE:"FOXO2" OR ABSTRACT:"FOXO2" OR TITLE:"FKHRL1" OR ABSTRACT:"FKHRL1") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about FOXO3, not a curated reading list.

Export

The dossier as machine-readable JSON: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/foxo3.json. Licence CC BY-NC 4.0.